Trademark Search  /  NUCLEIX

NUCLEIX

○ Dead · Abandoned

U.S. federal trademark · Serial No. 86639348

Mark
NUCLEIX
Status
Abandoned
Serial Number
86639348
Filing Date
May 22, 2015
Class(es)
Class 001, Class 005, Class 010, Class 042, Class 044

Owners

Nucleix, Ltd.
03 · Tel-Aviv, IL
Nucleix, Ltd.
03 · Tel-Aviv, IL

Goods & Services

Biochemical reagents for non-medical purposes; diagnostic preparations and reagents for scientific or research use; chemical and diagnostic preparations for clinical or medical laboratory use

Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection; diagnostic reagents for medical purposes

Pharmaceutical research and development; consulting services in the fields of biotechnology and pharmaceutical research and development; custom design and development of chemical reagents and biochemical assays

Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and prognosis of expected progression of the disease; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer; providing cancer screening services; providing a website featuring information in the fields of the diagnosis and treatment of cancer

Apparatus for medical diagnostic testing in the field of cancer

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "NUCLEIX" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.